Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN DIEGO, May 7, 2013 (GLOBE NEWSWIRE) -- The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) are pleased to announce the publication of the joint...
-
FAIRFAX, Va., April 19, 2013 (GLOBE NEWSWIRE) -- The Alliance for Integrity in Medicare (AIM), a broad coalition of medical specialty, laboratory, radiation oncology, and medical imaging groups...
-
FAIRFAX, Va., April 11, 2013 (GLOBE NEWSWIRE) -- The Alliance for Integrity in Medicare (AIM)- a broad coalition of medical specialty, laboratory, radiation oncology, and medical imaging groups...
-
FAIRFAX, Va., Nov. 2, 2012 (GLOBE NEWSWIRE) -- The Centers for Medicare and Medicaid Services (CMS) issued the final rule on November 1, 2012, that will revise several reimbursement payment policies...
-
BOSTON, Oct. 31, 2012 (GLOBE NEWSWIRE) -- The first trial of safety and toxicity shows promise for stereotactic radiosurgery as a therapeutic option for patients with localized primary renal cancer...
-
BOSTON, Oct. 30, 2012 (GLOBE NEWSWIRE) -- Stereotactic body radiotherapy (SBRT) yields excellent cancer-free survival rates for intermediate-risk, organ-confined prostate cancer patients and results...
-
BOSTON, Oct. 30, 2012 (GLOBE NEWSWIRE) -- Patients with organ-confined prostate cancer have new treatment options using high doses of focused stereotactic body radiotherapy (SBRT) instead of...
-
BOSTON, Oct. 30, 2012 (GLOBE NEWSWIRE) -- Annual prostate-specific antigen (PSA) screening yields a greater quality-adjusted life expectancy (QALE) among patients who have a high-risk of developing...
-
BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Accelerated partial breast irradiation using 3-D conformal external beam radiation therapy is associated with a negative cosmetic outcome compared to whole...
-
BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Stereotactic body radiation therapy (SBRT) yielded higher overall survival rates and low toxicity for patients with inoperable, non-small cell lung cancer...